AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT00911885 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Dietary Intervention
Description: The efficacy of the two dietary change interventions will be compared in a randomized controlled trial, with 120 patients per group. The two approaches are 1) the American Heart Association (AHA) Dietary Guidelines; and 2) a simple dietary change condition that focuses on increasing fiber. Patients in both conditions will receive intensive dietary instruction for 3 months, followed by a 9 month maintenance phase. Both conditions will receive dietary instructions via individual and group sessions led by registered dietitians.
Study NCT03207165 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Milrinone
Description: Patients will be initiated on Milrinone at 0.125 mcg/kg/min \[stage 1\] and will be titrated according to a blinded protocol from stages 2 to 5 \[0.250, 0.375, 0.5 and >0.5 ug/kg/min\]. All orders to initiate and titrate the dose of the allocated inotrope will be written in the chart as follows: 'Study inotrope dose to be \[increased/decreased/maintained\] at stage \[1-5\]' so as to ensure that treating physicians remain blinded to the allocated drug.
Study NCT03207165 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Dobutamine
Description: Patients will be initiated on Dobutamine at 2.5 mcg/kg/min \[stage 1\] and will be titrated according to a blinded protocol from stages 2 to 5 \[5.0, 7.5, 10 and >10 ug/kg/min\]. All orders to initiate and titrate the dose of the allocated inotrope will be written in the chart as follows: 'Study inotrope dose to be \[increased/decreased/maintained\] at stage \[1-5\]' so as to ensure that treating physicians remain blinded to the allocated drug.
Study NCT02866955 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Estramustine
Description: 140mg/4 caps/day
Study NCT02866955 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Tamoxifen
Description: 20mg/day
Study NCT02942940 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: mobile app
Description: The mobile app follow-up group will have no planned in-person follow-up, however these visits will be replaced with surgical site examination via submitted photos, Visual Analogue Scale (VAS), and Quality of Recovery - 9 questionnaire (QoR-9) and limb specific recovery monitoring. All information is submitted with the mobile app (QoC Health Inc, Toronto).
Study NCT02942940 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: conventional in-person
Description: Patients in the conventional follow-up group will have a planned clinic follow-up at 2 and 6 weeks post-operatively, which is the schedule currently used by our surgeons. At these scheduled follow-up visits, patients will be asked to complete the VAS to assess pain and the QoR-9 in addition to recovery questions about their operated extremity.
Study NCT03661879 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: NNC9204-1706
Description: Participants will receive NNC9204-1706 subcutaneous (s.c., under the skin) injection(s) once daily (OD) for 10 weeks. They will either receive the same dose throughout the trial, or the dose will be escalated over a period of 1-3 weeks and continued for at least 7 weeks at the same dose.
Study NCT03661879 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo (NNC9204-1706)
Description: Participants will receive matching placebo (NNC9204-1706) s.c., injection(s) OD for 10 weeks.
Study NCT02551796 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: lenticule extraction
Description: Four femtosecond incisions will be created in succession: the posterior surface of the refractive lenticule (spiral in), the lenticule border, the anterior surface of the refractive lenticule (spiral out), and the corneal flap in the superior region. After the suction is released, the flap will be opened using a thin, blunt spatula and the free refractive lenticule will be subsequently grasped with a forceps and extracted, after which the flap will be repositioned carefully.
Study NCT02551796 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: laser in situ keratomileusis
Description: During LASIK surgery, the eye will be gently proptosed and a hinged corneal flap will be cut using a microkeratome. The flap will be lifted and the stromal bed will receive a 6 mm diameter and stroma ablation. Finally reposition the flap carefully.
Study NCT03243630 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Menthol flavor
Description: American e-liquids' menthol flavor used in e-cigarettes will be used as the placebo comparator
Study NCT03243630 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: green apple
Description: green apple will be added to the menthol flavor
Study NCT03243630 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: green apple
Description: green apple will be added to the menthol flavor
Study NCT00562341 — intervention group
Intervention type: OTHER
Intervention: Bariatric Surgery
Description: one time lapb-band gastric bypass surgery
Study NCT03243630 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: green apple and menthol
Description: menthol and green apple will be the active intervention
Study NCT03243630 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: green apple and menthol
Description: menthol and green apple will be the active intervention
Study NCT03626649 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: DiamondTemp Cardiac Ablation System
Description: The DiamondTemp Ablation System is the test device in this investigational study. The DiamondTemp Ablation System consists of:~* DiamondTemp Ablation Catheter~  o Unidirectional and Bidirectional models~* DiamondTemp Catheter-to RFG Cable~* DiamondTemp GenConnect Cable~* DiamondTemp FASTR Generator with Footswitch~* DiamondTemp Irrigation Pump~* DiamondTemp Irrigation Tubing Set
Study NCT01424293 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Indocyanine Green
Description: 1ml of intravenous ICG and imaging transanally using the Spyscope system
Study NCT01424293 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: The SPY® Intraoperative Imaging System
Study NCT04829162 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Mother with obesity, daughter with obesity
Description: Participants in this group were shown an image of a mother with obesity and a daughter with obesity.
Study NCT04829162 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Mother with obesity, daughter without obesity
Description: Participants in this group were shown an image of a mother with obesity and a daughter without obesity.
Study NCT02551796 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: FS assisted laser in situ keratomileusis
Description: Track distance and spot distance will be 3.0 μm during flap creation and 1.5 μm during flap side-cutting. The flap diameter will be 8.0 mm, and flap thickness will be set to 105 μm. Side-cut angle and hinge angle will be 90°and 50° respectively. The flaps will be created by laser scanning in spirals from the periphery to the center of the pupil. An excimer laser system will be used in the subsequent ablation of thstromal bed with a 6.0 mm optical zone. Once the excimer. ablation is completed, the flap will be repositioned in a similar fashion as in routine LASIK.
Study NCT02901327 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Lumbar Stabilisation Exercise
Description: McGill protocol starting with:~1. 'cat-camel' exercise exercise 10 repetitions with 7 seconds hold each~2. 'curl-up' exercise 10 repetitions with 7 seconds hold each~3. 'side-bridge' exercise 10 repetitions with 7 seconds hold each~4. 'cat-camel' exercise 10 repetitions with 7 seconds hold each progression was based on subjects' tolerance and endurance.
Study NCT02901327 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: treadmill walk exercise
Description: Bruce protocol~This include:~1. '5 minutes warm up' at zero degree inclination.~2. '20 minutes active exercise with increasing speed and inclination'~3. '5 minutes cool down'
Study NCT00984113 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Elinogrel
Description: 100 mg elinogrel b.i.d. with aspirin q.d. for 7 days and aspirin alone for 4 days (Dose of aspirin is 81 mg in the US and 100 mg in Germany)
Study NCT04193462 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Post-partum depression- Dyadic psychotherapy-
Description: Mothers and infants will be treated with dyadic psychotherapy focused on interactions, emphasizing eye contact, body language, empathy, and social reciprocity. Dyadic psychotherapy will be administered one time a week during the 8-week trial period, at the subject's home. Each session, approximately 90 minutes long, will include videotaping mother-infant interaction, watching the last session's interaction as a part of video-feedback technique, and discussing main issues in the mother-infant relationship. In addition, each session will begin and end with a- 5-minute episode of affectionate touch and gaze synchrony between the mother and her infant. During the whole therapy-trial, the therapist will also use cognitive-behavioral approach to address the mother's perception of her infant and of herself as a mother.
Study NCT04193462 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Post-partum depression- Psycho-educational therapy
Description: Mothers will receive a therapy in their homes for 8 weeks, 1.5 hours for each session by a therapist arriving at their home. Each session will address a different developmental aspects of the baby (feeding, movement, social-emotional development etc.). Therapist will ask the mother about her baby, will give information about developmental needs and expectations and will help mother to enrich child's development and deal will potential problems
Study NCT02208687 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Energetic
Description: Physiotherapy and occupational therapy aimed at reconditioning and social participation.
Study NCT02208687 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Control group
Description: Usual care
Study NCT03905044 — intervention group
Intervention type: OTHER
Intervention: eyes with congenital cataracts
Description: observation
Study NCT00213993 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: antiperspirant
Description: antiperspirant topically once daily to one foot
Study NCT03927560 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Robotic Assisted Percutaneous Coronary Intervention
Description: Robotic Assisted Percutaneous Coronary Intervention
Study NCT04935645 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Progressive Muscle Relaxation
Description: PMR is a technique that provides relaxation in the whole body by voluntary and regular relaxation of large muscle groups in the human body, which is included in mind-body applications.
Study NCT03686267 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: opaqued titanium abutments
Description: masking metallic color of titanium abutments by opaque porcelain
Study NCT03686267 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: lithium disilicate coping (high opacity)
Description: masking metallic color of titanium abutments using lithium disilicate copings
Study NCT03686267 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: titanium abutment with no color masking
Description: color masking methods are avoided in this arm
Study NCT01813994 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Arm2: Placebo
Description: Study1 (only H. pylori infected patients) Arm2: All patients undergo H. pylori eradication therapy after 2 weeks from the endoscopic submucosal dissection. In this arm2, all patients take placebos for 6 months. Then, follow-up endoscopy for gastric biopsy and CLO test will be performed after 6.5 months from the endoscopic submucosal dissection.~Study2 (only H. pylori non-infected patients) Arm2: In this arm2, all patients start taking placebos after 2 weeks from the endoscopic submucosal dissection. Follow-up endoscopy for gastric biopsy will be performed after 6.5 months from the endoscopic submucosal dissection.
Study NCT04653467 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GLPG4399 oral suspension
Description: GLPG4399 for oral administration
Study NCT04653467 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GLPG4399 capsules
Description: GLPG4399 for oral administration
Study NCT04653467 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo oral suspension
Study NCT01117909 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Mobilization therapy in addition to standard therapy
Description: Subject will receive three 60-second bouts of posterior joint mobilizations applied to the ankle joint during each treatment session. Standard therapy will consist of ankle strengthening exercises with elastic bands, balance, active ROM, and 20 minutes of ice bag application, elevation and compression.
Study NCT01117909 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Sham intervention
Description: Physical therapist will lay hands as if to perform the joint mobilization but no movement will occur.
Study NCT00220922 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Alcohol Wipes vs. No Alcohol Wipes
Study NCT01426542 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Topiramate
Description: Topiramate 5 mg/kg by mouth (or by feeding tube) once a day for one week before and one week after heart surgery.
Study NCT01426542 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: No medication, but routine heart surgery
Description: No medication, but routine heart surgery
Study NCT05185206 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Class 1 cavity preparation using conventional steel bur and restoration with Cention-n(commercially available restorative material).
Description: Patients aged between 18 and 55 years having class 1 occlusal caries(1.2 according to G. J. Mount classification) on both sides of arch. In order to standardise the cavity preparation depth(approximately 1.5 to 2mm from the roof of the pulp chamber), the distance from occlusal surface to roof of pulp chamber will be used for measuring with the radiograph. This will be followed by caries removal with convention steel bur followed by restoration with Cention-n and checking of postoperative sensitivity using Visual Analog Scale.The Visual Analog Scale consists of a 100-mm line divided into equal intervals of 10 mm, where 0 represents absence of pain and 100 severe pain. The results of Visual Analog Scale will be classified as mild (0-30 mm), moderate (40-70 mm), or severe pain (> 70 mm).
Study NCT05185206 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Class 1 cavity preparation using polymer bur and restoration with Cention-n(commercially available restorative material).
Description: Patients aged between 18 and 55 years having class 1 occlusal caries(1.2 according to G. J. Mount classification) on both sides of arch. In order to standardise the cavity preparation depth(approximately 1.5 to 2mm from the roof of the pulp chamber), the distance from occlusal surface to roof of pulp chamber will be used for measuring with the radiograph. This will be followed by caries removal with polymer bur followed by restoration with Cention-n and checking of postoperative sensitivity using Visual Analog scale.The Visual Analog Scale consists of a 100-mm line divided into equal intervals of 10 mm, where 0 represents absence of pain and 100 severe pain. The results of Visual Analog Scale will be classified as mild (0-30 mm), moderate (40-70 mm), or severe pain (> 70 mm).
Study NCT02586506 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo ELLIPTA inhaler
Description: The ELLIPTA Dry Powder Inhaler (DPI) is a molded plastic two-sided inhaler that can hold two individual blister strips. Each strip will contain either lactose or a blend of lactose and magnesium stearate. Subjects will receive 1 inhalation once-daily until visit 2.
Study NCT02586506 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Questionnaire
Description: ELLIPTA Inhaler Ease of Use Questionnaire is a four-point Likert scale. This questionnaire will be filled by investigator (designee) based on responses received from subject. Responses for the questionnaire are Very difficult, Difficult, Easy, Very easy. Subjects will be give either version A or B at Visit 2.
Study NCT01566214 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Motivational Interview
Description: For those subjects randomly assigned to the treatment group, information from their MIHART assessment interview and medical record review will be used to select intervention scripts optimally tailored to each subjects' unique configuration of beliefs and risk factors and they will be re-contacted by telephone at 2-weeks post-hospital discharge to deliver the Vet-HART intervention. The intervention will be administered by a trained research assistant via telephone, working from a semi-structured script tailored to each subject's representations and risk factors, the call will last about 15-30 minutes.
Study NCT03540251 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Auricular Points Sticking
Description: Auricular Points Sticking is a kind of acupunture based on Meridians Theory of traditional Chinese Medicine.Sticking and pressing predefined therapeutic auricular points can relieve the frequency and severity of hot flashes and other climacteric symptoms.~Both groups received a booklet with information about self-care indications, auricular points and its management, and patients can record their hot flash score each day for 12 weeks in the booklets.In addition, both group received 8 treatment sessions of sticking and pressing predefined auricular points or placebo auricular points treatments.
Study NCT03540251 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Auricular Points Sticking
Description: Auricular Points Sticking is a kind of acupunture based on Meridians Theory of traditional Chinese Medicine.Sticking and pressing predefined therapeutic auricular points can relieve the frequency and severity of hot flashes and other climacteric symptoms.~Both groups received a booklet with information about self-care indications, auricular points and its management, and patients can record their hot flash score each day for 12 weeks in the booklets.In addition, both group received 8 treatment sessions of sticking and pressing predefined auricular points or placebo auricular points treatments.
Study NCT00316108 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: WALLSTENT® Endoprosthesis™
Description: Carotid Artery Stent
Study NCT04734678 — intervention group
Intervention type: DRUG
Intervention: Tocilizumab
Description: 400 mg IV only once
Study NCT04734678 — intervention group
Intervention type: DRUG
Intervention: Infliximab
Description: 5 mg/kg/day IV for 2 doses 12-24 hours
Study NCT00393510 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: TCM
Description: The Decoction is taken orally, twice a day, treatment period is 24 weeks The herbal formulation or a placebo was given as an adjuvant therapy for the treatment of the unhealing ulcers in these diabetic patients.~The formula consisted of 12 herbs, viz:~Radix astragali, Rhizoma atractylodis marcocephalae, Radix stephaniae tetrandrae, Radix polygoni multiflori, Radix rehmanniae, Radix smilax china, Fructus corni, Rhizoma dioscoreae, Cortex moutan, Rhizoma alismatis, Rhizoma smilacis glabrae, and Fructus schisandrae
Study NCT00393510 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo taking orally, twice a day, 24 week treatment period The herbal formulation or a placebo was given as an adjuvant therapy for the treatment of the unhealing ulcers in these diabetic patients.~The placebo was made with starch and colouring materials.
Study NCT01297777 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Imatinib Mesylate
Description: * In patients without B or C findings and without biological progression: 300 mg/24 h p.o during one year or until progression/unacceptable toxicity.~* In patients with B or C findings or biological progression: 300 mg/24 h p.o for two weeks and then 400 mg/24 h p.o for a total of one year of therapy, or until progression/unacceptable toxicity.
Study NCT01073046 — intervention group
Intervention type: DEVICE
Intervention: Naso-Gastric/Jejunal Tube
Description: Silastic Naso-Gastric/Jejunal Tube (Rusch® distributed by Teleflex Medical Srl)
Study NCT04335214 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: one to one interview
Description: one to one interviews with older people from moroccon origin in Belgium
Study NCT01402856 — intervention group
Intervention type: OTHER
Intervention: Education
Description: An educational program targeting HS students on the risks of distracted driving that was 60-min long \& utilized: a 5-10 min DVD on a teenager's real-life experience of the devastating effects of distracted driving, other videos placing the viewer in the driver's seat, power point presentations of state and national statistics related to seat belt usage, mortality, and substance use, overview of state laws, demonstrations of the physics of an accident, \& interactive games simulating distracted driving.
Study NCT01402336 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GnRH antagonist (Cetrorelix)
Description: In the first arm, cetrotide will be administrated from the first day during stimulation. In the second arm, cetrotide will be administrated from the sixth day during stimulation
Study NCT01402336 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Conventional GnRH agonist (Triptorelin)
Description: Patients in the agonist group were administered GnRH agonist started 5 days before discontinuation of the oral contraceptive.
Study NCT00748020 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: UVB phototherapy
Description: Group 1: every irradiation an increase of 40%, starting with 70% of the minimal erythema dose
Study NCT00748020 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: UVB phototherapy
Description: Group 2: every irradiation an increase of 20%, starting with 30% of the minimal erythema dose